30/03/2026
*RRIUM Bhadrak Honoured at National AYUSH Pharmacovigilance Training Programme*
The Regional Research Institute of Unani Medicine (RRIUM Bhadrak), an NABH-accredited and NABL-certified institute, marked a significant achievement by actively participating in the *Orientation-cum-Hands-On Training Programme on AYUSH Suraksha Portal* held on March 27–28, 2026 at the National Institute of Unani Medicine, Bengaluru.
The programme was organized by the Intermediary Pharmacovigilance Centre (IPvC) for Unani Drugs under the aegis of the National Institute of Unani Medicine, Bengaluru, with a focus on strengthening pharmacovigilance practices in the Unani system of medicine.
Representing the institute, Dr. M. A. Waheed, Research Officer, (Unani) and Dr. Md. Shaharyar Ali Ansari, Junior Research Fellow (Unani) actively participated in the training sessions. The programme emphasized effective utilization of the AYUSH Suraksha Portal for monitoring the safety and efficacy of Unani drugs.
In a moment of pride, RRIUM Bhadrak was recognized *for the first time* as one of the **Best Performing Institutes** among Peripheral Pharmacovigilance Centres. This recognition highlights the institute’s consistent efforts in ensuring drug safety, adverse drug reaction reporting, and strengthening pharmacovigilance mechanisms.
The valedictory session was graced by Chief Guest Dr. Younis Iftikhar Munshi, Deputy Director General, Central Council for Research in Unani Medicine, Ministry of Ayush, Government of India. His address underscored the growing importance of pharmacovigilance in traditional systems of medicine.
The programme was also attended by distinguished dignitaries including Prof. Ghulamuddin Sofi, Director Incharge, NIUM Bengaluru, Dr. Ruknuddin Galib, Coordinator, National Pharmacovigilance Centre (NPvCC) AIIA, New Delhi, and Prof. Mohd. Aleemuddin Quamri, Coordinator, Intermediary Pharmacovigilance Centre (IPvC), NIUM Bengaluru.
The training programme served as a vital platform for knowledge exchange, capacity building, and reinforcing the commitment of Unani institutions toward patient safety and pharmacovigilance excellence. The recognition received by RRIUM Bhadrak further strengthens its role as a key contributor to the national pharmacovigilance network for Unani medicine.